Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences (Nasdaq: OACC) is a blank-check company sponsored by Oaktree Capital Management, the Los Angeles-based alternative investment manager with expertise across credit, private equity, and real assets. The vehicle is the third special purpose acquisition company in Oaktree's SPAC series and is focused on identifying a business combination target within the life sciences sector, encompassing biotechnology, pharmaceuticals, diagnostics, and medical technology. The company filed a Form 10-Q with the SEC on November 13, 2025, under accession number 0001193125-25-280296, indicating it remains active as a listed vehicle. Sign up for SpacDesk to access complete filing history, deal timelines, and real-time analytics for OACC and hundreds of other active SPAC transactions.